Mele Aparna MD - Reading, Pennsylvania 19610

Mele Aparna MD is categorized under Doctors in Reading, PA .

Business Name: Mele Aparna MD
Contact Person: Aparna Mele
Address: 1011 Reed Avenue # 300, Reading, Pennsylvania 19610
Phone Number: (610) 374-4401
Website Address: dda-berks.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Emkey Kenneth D MD - Reading, PA 19610
Koo Winifred W MD - Reading, PA 19610
Nagy Robert MD - Reading, PA 19610
O'Rourke David B MD - Reading, PA 19610
James S Goodhart Dr - Reading, PA 19610
Berks Eye Phys & Surgeons - Reading, PA 19610
Reuben Mark MD - Reading, PA 19610
Franklin D Deguzman Md - Reading, PA 19610
Dental Arts of Wyomissing - Reading, PA 19610
Kim James N MD - Reading, PA 19610
Pennsylvania Eye & Ear Surgery - Reading, PA 19610
Ohnsman Christina M MD - Reading, PA 19610
Hein Edward W MD - Reading, PA 19610
Noori Saum A MD - Reading, PA 19610
Ravetz Pamela C MD - Reading, PA 19610
Scollan David F MD - Reading, PA 19610
Staub Todd A MD - Reading, PA 19610
Kim Sanghoom MD - Reading, PA 19610
Piegari Guy N MD - Reading, PA 19610
Reedy Brian K MD - Reading, PA 19610

The company Mele Aparna MD provides B2C services in the form of Doctors from its single location in Pennsylvania. 1 to 4 employees work for Mele Aparna MD, and the business now earns $500.000 to $999.999 per annum.

Mele Aparna MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Mele Aparna MD, please call Aparna Mele with the phone number (610) 374-4401 or visit its single location at 1011 Reed Avenue # 300 in Reading, Pennsylvania 19610.

The location of the single location can also be found using the coordinates 40.33775,-75.9638. Read more details about this business on the webpage dda-berks.com or follow the company’s social media accounts, on Twitter and on Facebook.